Baqsimi® (glukagon näspulver): Användning vid graviditet och amning

Detailed Information

Pregnancy

NG can be used during pregnancy. Glucagon does not cross the human placental barrier. The use of glucagon has been reported in pregnant women with diabetes and no harmful effects are known with respect to the course of pregnancy and the health of the unborn and the neonate.¹

Lactation

NG can be used during breast-feeding. Glucagon is cleared from the bloodstream very quickly  and thus the amount excreted in the milk of nursing mothers following treatment of severe hypoglycaemic reactions is expected to be extremely small. As glucagon is degraded in the digestive tract and cannot be absorbed in its intact form, it will not exert any metabolic effect in the child. ¹

References

1. Baqsimi [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Glossary

GI = gastrointestinal

NG = nasal glucagon (glucagon nasal powder)